Non-transfusion-dependent thalassemia encompasses three clinically distinct forms -- beta-thalassaemia intermedia, hemoglobin E/beta-thalassaemia (mild and moderate forms), and al ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...

An estimated 12,000 children are born with thalassemia major, a severe form of the disease, in India each year, accounting ...

DKMS Foundation India inaugurates new BMT unit in Ahmedabad, providing hope and treatment for thalassemia patients in Gujarat ...

Meerut: A 12-bed thalassemia ward at Saharanpur district hospital now provides free treatment to nearly 145 patients, thanks ...

Commissioner Sargodha Division Jahanzeb Awan visited the Thalassemia and Hemophilia Centre at Hilal-e-Ahmer Hospital to review the ...

A Thalassemia screening desk has been inaugurated at the NADRA centre in Sukkur on Saturday marking a significant step ...

Cash, cash equivalents and marketable securities as of December 31, 2024, were $1.5 billion compared to $806.4 million as of December 31, 2023.

Global Thalassemia Market Global Thalassemia Market Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Thalassemia Market by Treatment Type, by Type, by Distribution Channel, and by Region" report has ...

Filed for Regulatory Approval of Mitapivat (PYRUKYND®) for the Treatment of Adult Patients with Non-Transfusion-Dependent and ...